Is platelet monitoring during 7-day lusutrombopag treatment necessary in chronic liver disease patients with thrombocytopenia undergoing planned invasive procedures? A phase IIIb open-label study.

Numata, Kazushi; Tanaka, Katsuaki; Katsube, Takayuki; Ochiai, Toshimitsu; Fukuhara, Takahiro; Kano, Takeshi; Osaki, Yukio; Izumi, Namiki; Imawari, Michio

Numata, Kazushi; Tanaka, Katsuaki; Katsube, Takayuki; Ochiai, Toshimitsu; Fukuhara, Takahiro; Kano, Takeshi; Osaki, Yukio; Izumi, Namiki; Imawari, Michio.

Afiliación

Numata K; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
Tanaka K; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
Katsube T; Gastroenterological Center, Japanese Red Cross Hadano Hospital, Hadano, Japan.
Ochiai T; Clinical Pharmacology and Pharmacokinetics, Shionogi & Co., Ltd., Osaka, Japan.
Fukuhara T; Biostatistics Center, Shionogi & Co., Ltd., Osaka, Japan.
Kano T; Clinical Development, Shionogi & Co., Ltd., Osaka, Japan.
Osaki Y; Project Management, Shionogi & Co., Ltd., Osaka, Japan.
Izumi N; Department of Gastroenterology and Hepatology, Japanese Red Cross Society Osaka Hospital, Osaka, Japan.
Imawari M; Department of Gastroenterology and Hepatology, Meiwa Hospital, Nishinomiya, Japan.

Hepatol Res ; 50(10): 1141-1150, 2020 Oct.

Article en En | MEDLINE | ID: mdl-32609920

Palabras clave

liver disease; lusutrombopag; monitoring, physiologic; platelet count; pre-exposure prophylaxis; thrombocytopenia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Hepatol Res Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google